Napolitano A, d'Ischia M, Prota G, Havens M, Tramposch K
Department of Organic and Biological Chemistry, University of Naples, Italy.
Biochim Biophys Acta. 1991 Mar 4;1073(2):416-22. doi: 10.1016/0304-4165(91)90151-6.
As a part of an ongoing project aimed at developing new skin depigmenting agents, the ability of variously substituted 2-aryl-1,3-thiazolidines to inhibit melanogenesis in vitro was investigated. At 0.2 mM concentration 2-(2'-hydroxyphenyl)-1,3-thiazolidine-4-carboxylic acid (Th2), as well as the descarboxy analog (Th1) and, to a lower extent, the 4'-hydroxy isomer (Th3) all proved capable of preventing the tyrosinase catalyzed conversion of 0.2 mM L-tyrosine to melanin. Spectrophotometric monitoring of the reaction course in the presence of Th2 showed the initial formation of a yellow chromophore (lambda max 400 nm) which slowly decayed, being eventually replaced by a new absorption maximum centered at 305 nm. HPLC analysis of the final incubation mixture revealed the presence of a major product (lambda max 306 nm), ninhydrin and ferric chloride positive, which was isolated by gel filtration on Sephadex G-10 and was identified as beta-[7-(3-carboxy-5-hydroxy-3,4-dihydro-2H-1,4-benzothiazinyl)]al anine (DBA) by 1H-NMR spectroscopy. Attempts to isolate the intermediate with lambda max 400 nm were hampered by its marked instability under the usual chromatographic conditions. However, the nature of the chromophore, coupled with mechanistic considerations, suggested for the compound the Schiff base-containing structure 3,4-dihydroxy-5-S-(N-salicylidenecysteinyl)phenylalanine (salcysdopa). This was substantiated by: (i) the formation of a zinc complex (lambda max 349 nm) analogous to that observed with the model Schiff base N-salicylidene leucine; and (ii) detection by 1H-NMR of a Schiff base resonance at delta 8.1 during the yellow chromophoric phase of the reaction. It was concluded that 1,3-thiazolidines inhibit melanin formation by a mechanism that involves the trapping of enzymically generated dopaquinone by the -SH containing Schiff base arising by cleavage of the thiazolidine ring. The salcysdopa adduct thus formed undergoes hydrolysis and subsequent ring closure to give eventually the colorless DBA.
作为一个旨在开发新型皮肤色素脱失剂的正在进行的项目的一部分,研究了各种取代的2-芳基-1,3-噻唑烷在体外抑制黑色素生成的能力。在0.2 mM浓度下,2-(2'-羟基苯基)-1,3-噻唑烷-4-羧酸(Th2),以及脱羧类似物(Th1),以及较低程度的4'-羟基异构体(Th3),都被证明能够阻止酪氨酸酶催化0.2 mM L-酪氨酸转化为黑色素。在Th2存在下对反应过程进行分光光度监测,结果显示最初形成了一种黄色发色团(最大吸收波长400 nm),该发色团缓慢衰减,最终被一个以305 nm为中心的新的吸收最大值所取代。对最终孵育混合物进行HPLC分析,发现存在一种主要产物(最大吸收波长306 nm),茚三酮和氯化铁呈阳性,通过Sephadex G-10凝胶过滤法分离得到该产物,并通过1H-NMR光谱鉴定为β-[7-(3-羧基-5-羟基-3,4-二氢-2H-1,4-苯并噻嗪基)]丙氨酸(DBA)。在通常的色谱条件下,由于其明显的不稳定性,试图分离最大吸收波长为400 nm的中间体受到了阻碍。然而,发色团的性质,结合机理考虑,表明该化合物具有含席夫碱的结构3,4-二羟基-5-S-(N-水杨基亚氨基半胱氨酸基)苯丙氨酸(salcysdopa)。这一点得到了以下两点的证实:(i)形成了一种锌配合物(最大吸收波长349 nm),类似于在模型席夫碱N-水杨基亚氨基亮氨酸中观察到的情况;(ii)在反应的黄色发色团阶段,通过1H-NMR检测到δ 8.1处的席夫碱共振。得出的结论是,1,3-噻唑烷通过一种机制抑制黑色素的形成,该机制涉及噻唑烷环裂解产生的含-SH的席夫碱捕获酶促生成的多巴醌。由此形成的salcysdopa加合物经过水解和随后的环化,最终生成无色的DBA。